Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Kinetic studies of the individual reaction of pig heart pyruvate dehydrogenase complex (pyruvate dehydrogenase (pyruvate:lipoamide oxidoreductase (decarboxylating and acceptor-acetylating), EC 1.2.4.1); dihydrolipoamide reductase(NAD+) (NADH:lipoamide oxidoreductase, EC 1.6.4.3);
dihydrolipoamide acetyltransferase
(acetyl-CoA:dihydrolipoamide S-acetyltransferase, EC 2.3.1.12)),
citrate synthase
(citrate oxaloacetate-lyase (pro-3S-CH2COO- leads to acetyl-CoA), EC 4.1.3.7) and the pyruvate dehydrogenase complex-
citrate synthase
coupled system show that the KmCoA value of pyruvate dehydrogenase complex and KmCoASAc value of
citrate synthase
decrease in the coupled system when compared to those in the individual enzyme reactions. The explanation for this interaction may be an association between the two enzymes. When it was centrifuged with 150 000 x g for 140 min, 30% of the
citrate synthase
sedimented in the presence of the pyruvate dehydrogenase complex, while no sedimentation was observed in the absence of the pyruvate dehydrogenase complex. Sedimentation of cytoplasmic malate dehydrogenase, phosphotransacetylase, hemoglobin and Blue albumin were negligible under the same condition. In gel chromatography experiments a significant peak of
citrate synthase
activity co-migrated with the pyruvate dehydrogenase complex peak. This observation also suggests the possible association of two enzymes.
...
PMID:Interaction between the pyruvate dehydrogenase complex and citrate synthase. 721 36